Design and synthesis of aryloxypropanolamine as β3-adrenergic receptor antagonist in cancer and lipolysis

被引：11
|
作者：
Jin, Jiyu [1 ]
Miao, Chunxiao [2 ]
Wang, Zhilong [3 ]
Zhang, Wanli [2 ]
Zhang, Xiongwen [2 ]
Xie, Xin [3 ,4 ]
Lu, Wei [1 ]
机构：
[1] East China Normal Univ, Sch Chem & Mol Engn, 3663 North Zhongshan Rd, Shanghai, Peoples R China
[2] East ChinaNormal Univ, Sch Chem & Mol Engn, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Shanghai, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, CAS Key Lab Receptor Res, Shanghai, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2018年 / 150卷
关键词：
beta-Adrenergic receptor; Antagonist; Cancer; Lipolysis and cachexia; MICE; METASTASIS; CACHEXIA; SWITCH;
D O I：
10.1016/j.ejmech.2018.03.032
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
beta-adrenergic receptors (beta-ARs) are broadly distributed in various tissues and regulate a panel of important physiological functions and disease states including cancer. Above all, beta(3)-adrenergic receptor (beta(3)-AR) plays a significant role in regulating lipolysis and thermogenesis in adipose tissue. In this study, we designed and synthesized a series of novel L-748,337 derivatives as selective human beta(3)-AR antagonists. Among all the tested L-748,337 analogs, compound 23d was found to display 23-fold more potent beta(3)-AR antagonist activity (EC50 = 0.5117 nM) than L-748,337 (EC50 = 11.91 nM). In vivo, compound 23d could alleviate weight loss and inhibit tumor growth in C26 tumor cachexia animal model. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：757 / 770
页数：14
相关论文
共 50 条
  • [21] Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β3 Adrenergic Receptor Agonists for the Treatment of Overactive Bladder
    Moyes, Christopher R.
    Berger, Richard
    Goble, Stephen D.
    Harper, Bart
    Shen, Dong-Ming
    Wang, Liping
    Bansal, Alka
    Brown, Patricia N.
    Chen, Airu S.
    Dingley, Karen H.
    Di Salvo, Jerry
    Fitzmaurice, Aileen
    Gichuru, Loise N.
    Hurley, Amanda L.
    Jochnowitz, Nina
    Miller, Randall R.
    Mistry, Shruty
    Nagabukuro, Hiroshi
    Salituro, Gino M.
    Sanfiz, Anthony
    Stevenson, Andra S.
    Villa, Katherine
    Zamlynny, Beata
    Struthers, Mary
    Weber, Ann E.
    Edmondson, Scott D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (04) : 1437 - 1453
  • [22] Differential involvement of caveolin-1 in brown adipocyte signaling: Impaired β3-adrenergic, but unaffected LPA, PDGF and EGF receptor signaling
    Mattsson, Charlotte L.
    Andersson, Emma R.
    Nedergaard, Jan
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (08): : 983 - 989
  • [23] Association of β3-adrenergic receptor rs4994 polymorphisms with the risk of type 2 diabetes: A systematic review and meta-analysis
    Ryuk, Jin Ah
    Zhang, Xin
    Ko, Byoung-Seob
    Daily, James W.
    Park, Sunmin
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 129 : 86 - 96
  • [24] Oxytocin and 'social hyperthermia': Interaction with β3-adrenergic receptor-mediated thermogenesis and significance for the expression of social behavior in male and female mice
    Harshaw, Christopher
    Lanzkowsky, Jessica
    Tran, Alexander-Quang Duc
    Bradley, Alana Rose
    Jaime, Mark
    HORMONES AND BEHAVIOR, 2021, 131
  • [25] Drug Repositioning of the α1-Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug?
    Florent, Romane
    Poulain, Laurent
    N'Diaye, Monique
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 21
  • [26] Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring
    Ohta, Kiminori
    Goto, Tokuhito
    Fijii, Shinya
    Suzuki, Tomoharu
    Ohta, Shigeru
    Endo, Yasuyuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (17) : 8022 - 8028
  • [27] β3-Adrenergic receptor blockade reduces mortality in endotoxin-induced heart failure by suppressing induced nitric oxide synthase and saving cardiac metabolism
    Kawaguchi, Satoshi
    Okada, Motoi
    Ijiri, Eriko
    Koga, Daisuke
    Watanabe, Tsuyoshi
    Hayashi, Kentaro
    Kashiwagi, Yuta
    Fujita, Satoshi
    Hasebe, Naoyuki
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2020, 318 (02): : H283 - H294
  • [28] Diastereoselective synthesis of the acid part of a new muscarinic M3 receptor antagonist
    Mitsuya, M
    Ogino, Y
    Ohtake, N
    Mase, T
    TETRAHEDRON, 2000, 56 (51) : 9901 - 9907
  • [29] 3′,4′-Dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells
    Lee, JE
    Safe, S
    TOXICOLOGICAL SCIENCES, 2000, 58 (02) : 235 - 242
  • [30] Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling
    Rousseau, Benedicte
    Murugan, Sengottuvelan
    Palagani, Ajay
    Sarkar, Dipak K.
    BREAST CANCER RESEARCH, 2022, 24 (01)
12345